Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 24, 2019 07:00 ET | Source: Streetwise Reports Llc

Streetwise Reports Examines the Commercial Launch Planned for Schizophrenia Drug

SAN FRANCISCO, Jan. 24, 2019 (GLOBE NEWSWIRE) -- DURECT Corp. (DRRX:NASDAQ), a biopharmaceutical company, noted that Indivior Plc announced that it will launch in the U.S. its drug for the treatment...
November 15, 2017 09:00 ET | Source: Streetwise Reports Llc

Streetwise Reports Examines How One Analyst Says This Biotech Company Could Potentially 'Double'

SAN FRANCISCO, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Analyst Grant Zeng of Zacks Small Cap Research examines what transpired with this biopharmaceutical company during Q3/17. Included in this article...